Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Process Development
49 Articles Available
0
3
Can't find what you're looking for? Try our
advanced search
.
Microfluidics
How Microfluidic Devices are Benefitting Biopharmaceutical Development and Manufacturing
PAO-04-24-NI-02
Viral Vectors
A Viral Vector CDMO Vision that Resonates
PAO-03-24-CL-06
Failing Fast
Maximizing Resources and Potential for Success by Failing Fast
PAO-10-23-CL-02
Clinical and Commercial Manufacturing
Reach the Patient Quicker with GBI’s Manufacturing Solutions
PAO-08-23-CL-02
Biocatalysis
Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme
PR-M05-23-02
Sustainable Manufacturing
Sustainability in Pharmaceutical Manufacturing: A CDMO’s Contribution
PAO-11-022-CL-07
Multispecific Antibodies
Optimized Multispecific Antibody Design, Development, and Manufacturing
PAO-08-022-CL-04
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
PR-M06-22-02
R&D
Driving Further Innovation by Integrating a Decentralized R&D Network
PAO-06-022-CL-02
Advanced Excipients
How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs
PAO-04-022-CL-07
Mesenchymal Stem Cells
A Media Platform for Cost-Effective and Scalable 2D and 3D Bioreactor MSC Expansion
PAO-04-022-CL-05
Aseptic Processing
Unique Manufacturing Challenges Associated with Sterile Eye Ointments
PAO-04-022-CL-04
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
PAO-04-022-CL-02
Process Validation
Streamlining Process Validation for Drug Substance Manufacturing
PAO-02-022-CL-19
Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and Manufacturing
PAO-02-022-CL-17
Manufacturing Authorization
Vetter’s New Clinical Manufacturing Site Now Officially Authorized
PR-M01-22-12
mRNA
Integrated Support Facilitates mRNA Product Development and Commercialization
PAO-10-21-CL-15
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
PAO-09-21-CL-05
Cell and Gene Therapy
6 Analytical Strategies to Consider Before Submitting Your Cell and Gene Therapy Application
PAO-06-21-CL-04
Synthetic Biology
An Unnatural Phenomenon: How Synthetic Biology May Disrupt Pharma and Beyond
PAO-06-21-NI-02
Gene Therapy
Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development
PAO-03-21-CL-08
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
PAO-01-21-CL-05
Process Development
Innovative Approach to Process Development
PAO-02-21-CL-02
Analytical Development
Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods
PAP-Q4-19-CL-017
«
0
3
»
.svg)
